KB Financial Partners’s Edwards Lifesciences EW Stock Holding History

KB Financial Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$2K	Sell	27 -2	-7%	-$161	﹤0.01%	508
2023 Q2	$3K	Hold	29	–	–	﹤0.01%	476
2023 Q1	$2K	Buy	29 +2	+7%	+$157	﹤0.01%	511
2022 Q4	$2K	Hold	27	–	–	﹤0.01%	511
2022 Q3	$2K	Buy	+27	New	+$2.6K	﹤0.01%	503
2022 Q2	–	Sell	-27	Closed	-$3K	–	590
2022 Q1	$3K	Sell	27 -4	-13%	-$449	﹤0.01%	506
2021 Q4	$4K	Buy	+31	New	+$3.62K	﹤0.01%	519
2021 Q3	–	Sell	-1,081	Closed	-$112K	–	300
2021 Q2	$112K	Sell	1,081 -25	-2%	-$2.36K	0.04%	199
2021 Q1	$93K	Buy	+1,106	New	+$93.5K	0.04%	210

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

KB Financial Partners's EW Position: Q3 2023 in Review

KB Financial Partners reduced its Edwards Lifesciences (EW) stake by 6.9% in Q3 2023, selling an estimated $161 and leaving 27 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #508.

KB Financial Partners first reported a position in EW in Q1 2021 and has held it in 9 quarters since. The position peaked at $112K in Q2 2021. 1,219 funds tracked by Wall St. Rank hold EW as of Q3 2023.

KB Financial Partners held 27 shares of Edwards Lifesciences worth $2K as of Q3 2023.
KB Financial Partners sold 2 Edwards Lifesciences shares in Q3 2023, an estimated $161.
Edwards Lifesciences made up ﹤0.01% of KB Financial Partners's portfolio in Q3 2023, its #508 holding.
KB Financial Partners first reported a position in Edwards Lifesciences in Q1 2021 and has held it in 9 quarters since.
KB Financial Partners's Edwards Lifesciences position peaked at $112K in Q2 2021.
1,219 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.